Latest News and Press Releases

RUTHERFORD, N.J., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today...

Los Angeles, CA, Sept. 06, 2019 (GLOBE NEWSWIRE) -- M2 Compliance ("M2"), a leading SEC registered filing agent, and financial printer will be proudly sponsoring the Rodman & Renshaw Conference,...

VANCOUVER, Colombie-Britannique, 28 août 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV : EMH ; OTCQX : EMHTF) a annoncé aujourd'hui qu'elle présentera un aperçu...

VANCOUVER, British Columbia, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that it will present a corporate overview and...

New York, Sept. 03, 2018 (GLOBE NEWSWIRE) -- M2 Compliance ("M2"), a global leading SEC registered filing agent and financial printer, announced it will be proudly sponsoring the 20th Annual Global...

WOBURN, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), a company focused on developing new technologies to achieve step-change improvements in crop yield to enhance...

CAMBRIDGE, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ:VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...

HIGHLANDS RANCH, Colo., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Advanced Emissions Solutions, Inc. (NASDAQ:ADES) (the "Company" or "ADES") today announced that the Company will be presenting at the...

WOBURN, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), a Company focused on developing new technologies to achieve step-change improvements in crop yield to...

NORCROSS, Ga., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that management will...